These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 19627007
1. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy]. Zhang LN, Xie XS, Zuo C, Fan JM. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007 [Abstract] [Full Text] [Related]
2. [Effects of ginsenoside Rg1 on streptozocin-induced diabetic nephropathy in rats]. Ma X, Xie X, Zuo C, Fan J. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):342-7. PubMed ID: 20481316 [Abstract] [Full Text] [Related]
3. Effect of retinoic acid in experimental diabetic nephropathy. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK, Kang SW, Han DS, Han JY, Cha DR. Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114 [Abstract] [Full Text] [Related]
4. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats. Zhang Y, Chen B, Hou XH, Guan GJ, Liu G, Liu HY, Li XG. Chin Med J (Engl); 2007 Jun 05; 120(11):988-95. PubMed ID: 17624267 [Abstract] [Full Text] [Related]
5. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats. Chen J, Chen Y, Luo Y, Gui D, Huang J, He D. Eur J Pharmacol; 2014 Aug 05; 736():86-94. PubMed ID: 24809932 [Abstract] [Full Text] [Related]
6. Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes. Marotta F, Harada M, Dallah ED, Yadav H, Solimene U, Di Lembo S, Minelli E, Jain S, Chui DH. J Biol Regul Homeost Agents; 2010 Aug 05; 24(1):41-9. PubMed ID: 20385070 [Abstract] [Full Text] [Related]
9. [Relation between bone matrix proteins and monocyte chemoattractant protein-1 in renal small artery in diabetic nephropathy rats]. Zhao AJ, Huang SM, Ou ST, Liu F, Chen ZJ, Hu ZX, Tang WX. Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May 05; 43(3):414-9. PubMed ID: 22812249 [Abstract] [Full Text] [Related]
10. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats. Peng T, Chang X, Wang J, Zhen J, Yang X, Hu Z. Mol Med Rep; 2017 May 05; 15(5):3172-3178. PubMed ID: 28339051 [Abstract] [Full Text] [Related]
12. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. Gui D, Huang J, Guo Y, Chen J, Chen Y, Xiao W, Liu X, Wang N. Cytokine; 2013 Mar 05; 61(3):970-7. PubMed ID: 23434274 [Abstract] [Full Text] [Related]
13. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics. Zhang H, Zhao T, Gong Y, Dong X, Zhang W, Sun S, Wang H, Gu Y, Lu X, Yan M, Li P. J Ethnopharmacol; 2014 Mar 05; 151(1):556-64. PubMed ID: 24269779 [Abstract] [Full Text] [Related]
17. Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model. Qiao L, Liu Y, Li C, Ge J, Li T. Pharmacology; 2019 Mar 05; 104(5-6):258-266. PubMed ID: 31344701 [Abstract] [Full Text] [Related]